AAIC 2025 Abstract
Exploring Low‐Intensity Focused‐ultrasound Neuromodulation in Alzheimer's Disease
Trial in peopleInterventions
Abstract
Background: Alzheimer's disease (AD) presents a major public health challenge with few effective therapeutic options. Monoclonal antibodies targeting β‐amyloid show promise, but their clinical efficacy remains modest.
